Artelo Biosciences
ARTL
ARTL
2 hedge funds and large institutions have $0 invested in Artelo Biosciences in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$0 |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Goldman Sachs
New York
| – | – | -14,223 | Closed |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| – | – | -700 | Closed |
|
|
CFGS
3
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
4
Wells Fargo
San Francisco,
California
| $0 | 18 | +1 | +6% |
|
5
Morgan Stanley
New York
| $0 | 162 | +162 | New |
|